TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 1 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $18,428,000 | +351.1% | 244,889 | +61.0% | 0.01% | +600.0% |
| Q1 2022 | $4,085,000 | -13.9% | 152,133 | +52.9% | 0.00% | 0.0% |
| Q4 2021 | $4,747,000 | -11.6% | 99,476 | +23.1% | 0.00% | -50.0% |
| Q3 2021 | $5,369,000 | +38.6% | 80,815 | +62.7% | 0.00% | +100.0% |
| Q2 2021 | $3,874,000 | -56.9% | 49,659 | -47.6% | 0.00% | -66.7% |
| Q1 2021 | $8,989,000 | +204.7% | 94,824 | +291.7% | 0.00% | +200.0% |
| Q4 2020 | $2,950,000 | – | 24,206 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 3,037,042 | $236,950,000 | 8.05% |
| MPM BioImpact LLC | 269,186 | $21,002,000 | 3.45% |
| Logos Global Management LP | 400,000 | $31,208,000 | 2.62% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 121,541 | $9,481,000 | 2.50% |
| Orbimed Advisors | 2,361,327 | $184,231,000 | 1.86% |
| First Light Asset Management, LLC | 395,825 | $30,882,000 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 211,650 | $16,513,000 | 1.34% |
| Nicholas Investment Partners, LP | 224,876 | $17,545,000 | 1.10% |
| DAFNA Capital Management LLC | 47,852 | $3,733,000 | 0.78% |
| Eventide Asset Management | 578,000 | $45,096,000 | 0.61% |